Synthetic gene in antibody drug discovery, undergoing clinical approval
Antibody Drug Discovery (ADD) is an arduous process that often starts with the extensive screening of antibody libraries to identify optimal candidates, namely those having high-affinity antigen binding and other desirable functional properties. For example, during the COVID-19 pandemic, discovering potent neutralizing anti-SARS-CoV-2 antibodies has been prioritized. From the early stages of the pandemic, neutralizing …
Synthetic gene in antibody drug discovery, undergoing clinical approval Read More »